«It affects many more children than brittle bone disease, so we're very hopeful that
sclerostin antibody therapy will be a useful treatment for them as well.
Not exact matches
Previous studies have shown that inhibiting
sclerostin through
antibody therapy is effective at increasing bone formation and strength.
While there was some loss in newly formed spongy bone, the researchers found that this could be remedied by using the
sclerostin antibody in combination with other
therapies.